Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
Nature Medicine2006Vol. 12(4), pp. 401–409
Citations Over TimeTop 1% of 2006 papers
Marion Ott, Manfred Schmidt, Kerstin Schwarzwaelder, Stefan Stein, Ulrich Siler, Ulrike Koehl, Hanno Glimm, Klaus Kühlcke, Andrea Schilz, Hana Kunkel, Sonja Naundorf, Andrea Brinkmann, Annette Deichmann, Marlene Fischer, Claudia R. Ball, Ingo H. Pilz, Cynthia E. Dunbar, Yang Du, Nancy A. Jenkins, Neal G. Copeland, Ursula Lüthi, Moustapha Hassan, Adrian J. Thrasher, Dieter Hoelzer, Christof von Kalle, Reinhard Seger, Manuel Grez
Related Papers
- → Recent Advances in Gene Therapy and Modeling of Chronic Granulomatous Disease(2019)6 cited
- Chronic granulomatous disease - primary phagocytic immunodeficiency(2009)
- → Variant of X-Linked Chronic Granulomatous Disease Revealed by a SevereBurkholderia cepaciaInvasive Infection in an Infant(2013)3 cited
- → Chronic granulomatous disease due to different mutations in patients from the same consanguineous extended family(2018)1 cited